Compare DEC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DEC | ABCL |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | DEC | ABCL |
|---|---|---|
| Price | $13.20 | $3.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $21.40 | $7.75 |
| AVG Volume (30 Days) | 538.4K | ★ 4.6M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 8.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,148,432,000.00 | $35,325,000.00 |
| Revenue This Year | $126.94 | $25.45 |
| Revenue Next Year | N/A | $10.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 64.19 | 7.17 |
| 52 Week Low | $10.08 | $1.89 |
| 52 Week High | $17.03 | $6.52 |
| Indicator | DEC | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 40.09 |
| Support Level | $12.80 | $2.93 |
| Resistance Level | $13.59 | $3.28 |
| Average True Range (ATR) | 0.41 | 0.23 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 71.36 | 26.30 |
Diversified Energy Co is an independent energy company focused on natural gas and liquids production, transportation, marketing and well retirement, located within the Appalachian and Central regions of the United States. Its principal focus is on enhancing producing wells, not drilling new wells, thereby allowing it to optimise PDP revenues and reduce costs. The company derives revenues from the sale of oil, natural gas and natural gas liquids.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.